NCT04184375 Cognitive Stimulation for Elderly Bipolar Patients
| NCT ID | NCT04184375 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier de la Rochelle Ré Aunis |
| Condition | Bipolar Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2021-03-04 |
| Primary Completion | 2026-03-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2021-03-04 with a primary completion date of 2026-03-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.
Eligibility Criteria
Pre-Inclusion Criteria: * age \> 65 years old * Diagnosis of bipolar illness for more than 10 years * Euthymic phase * Understands and speaks French * Free, informed and express consent Inclusion Criteria: * Mild to moderate neuro-cognitive impairments (MMS Test : 16 ≤ score \< 26) Exclusion Criteria: * Illiteracy * Patient participating in other therapeutic workshops (e. g. psycho-geriatric day hospital care, etc.) * Persons deprived of their liberty by a judicial or administrative decision * Persons of full age who are subject to a legal protection measure * Persons unable to consent * Persons who are not members of or beneficiaries of a social security scheme * Patient's refusal to participate in the study
Contact & Investigator
Pascale Puzos, MD
STUDY DIRECTOR
Groupe Hospitalier de la Rochelle Ré Aunis
Frequently Asked Questions
Who can join the NCT04184375 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Bipolar Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04184375 currently recruiting?
Yes, NCT04184375 is actively recruiting participants. Contact the research team at caroline.allix-beguec@ght-atlantique17.fr for enrollment information.
Where is the NCT04184375 trial being conducted?
This trial is being conducted at La Rochelle, France.
Who is sponsoring the NCT04184375 clinical trial?
NCT04184375 is sponsored by Groupe Hospitalier de la Rochelle Ré Aunis. The principal investigator is Pascale Puzos, MD at Groupe Hospitalier de la Rochelle Ré Aunis. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.